Association of tissue inhibitor of metalloproteinases-1 and Ki67 in estrogen receptor positive breast cancer
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Association of tissue inhibitor of metalloproteinases-1 and Ki67 in estrogen receptor positive breast cancer
Authors
Keywords
-
Journal
ACTA ONCOLOGICA
Volume 52, Issue 1, Pages 82-90
Publisher
Informa UK Limited
Online
2012-12-05
DOI
10.3109/0284186x.2012.734922
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Prognostic value of Bcl-2 in two independent populations of estrogen receptor positive breast cancer patients treated with adjuvant endocrine therapy
- (2012) Mathilde S. Larsen et al. ACTA ONCOLOGICA
- Tumor tissue inhibitor of metalloproteinases-1 (TIMP-1) in hormone-independent breast cancer might originate in stromal cells, and improves stratification of prognosis together with nodal status
- (2012) P. Kuvaja et al. EXPERIMENTAL CELL RESEARCH
- Is tissue inhibitor of metalloproteinase-1 a new prognosticator for breast cancer? An analysis of 266 cases
- (2012) Alessandro Neri et al. HUMAN PATHOLOGY
- Estrogen Receptor (ER) mRNA and ER-Related Gene Expression in Breast Cancers That Are 1% to 10% ER-Positive by Immunohistochemistry
- (2012) Takayuki Iwamoto et al. JOURNAL OF CLINICAL ONCOLOGY
- An Alternate Perspective on the Roles of TIMPs and MMPs in Pathology
- (2011) Craig S. Moore et al. AMERICAN JOURNAL OF PATHOLOGY
- Strategies for subtypes—dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011
- (2011) A. Goldhirsch et al. ANNALS OF ONCOLOGY
- A Comparison of PAM50 Intrinsic Subtyping with Immunohistochemistry and Clinical Prognostic Factors in Tamoxifen-Treated Estrogen Receptor-Positive Breast Cancer
- (2010) T. O. Nielsen et al. CLINICAL CANCER RESEARCH
- Lack of TIMP-1 tumour cell immunoreactivity predicts effect of adjuvant anthracycline-based chemotherapy in patients (n=647) with primary breast cancer. A Danish Breast Cancer Cooperative Group Study
- (2009) Gro L. Willemoe et al. EUROPEAN JOURNAL OF CANCER
- Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer
- (2009) Maggie C. U. Cheang et al. JNCI-Journal of the National Cancer Institute
- The clinical database and the treatment guidelines of the Danish Breast Cancer Cooperative Group (DBCG); its 30-years experience and future promise
- (2008) Susanne Møller et al. ACTA ONCOLOGICA
- TIMP-1 overexpression promotes tumorigenesis of MDA-MB-231 breast cancer cells and alters expression of a subset of cancer promoting genes in vivo distinct from those observed in vitro
- (2008) Rebecca L. H. Bigelow et al. BREAST CANCER RESEARCH AND TREATMENT
- Prognostic significance of MMP-9 and TIMP-1 serum and tissue expression in breast cancer
- (2008) Zheng-Sheng Wu et al. INTERNATIONAL JOURNAL OF CANCER
- Serum TIMP-1 and Response to the Aromatase Inhibitor Letrozole Versus Tamoxifen in Metastatic Breast Cancer
- (2008) Allan Lipton et al. JOURNAL OF CLINICAL ONCOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now